Search research articles
Contact Us
Filters
Showing results (151-160 of 193) with videos related to
Page
of 20
Sort By:
Translational Research : the Journal of Laboratory and Clinical Medicine
|
January 28, 2014
Prognostic advantage of irinotecan dose escalation according to uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) genotyping in patients with metastatic colorectal cancer treated with bevacizumab combined with 5-fluorouracil/leucovorin with irinotecan in a first-line setting
Chien-Yu Lu, Ching-Wen Huang, Huang-Ming Hu, et al.
Oncology Letters
|
August 13, 2020
Effect of <i>KRAS</i> and <i>NRAS</i> mutations on the prognosis of patients with synchronous metastatic colorectal cancer presenting with liver-only and lung-only metastases
Shih-Chang Chuang, Ching-Wen Huang, Yi-Ting Chen, et al.
Journal of Oncology
|
September 23, 2020
Observational Study Comparing Efficacy and Safety between Neoadjuvant Concurrent Chemoradiotherapy and Chemotherapy for Patients with Unresectable Locally Advanced or Metastatic Gastric Cancer
Yung-Sung Yeh, Ming-Yii Huang, Cheng-Jen Ma, et al.
BMC Cancer
|
December 17, 2013
The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer
Ching-Wen Huang, Hsiang-Lin Tsai, Yi-Ting Chen, et al.
Journal of Oncology
|
May 16, 2020
Predictive Value of FOLFOX-Based Regimen, Long Interval, Hemoglobin Levels and Clinical Negative Nodal Status, and Postchemoradiotherapy CEA Levels for Pathological Complete Response in Patients with Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy
Chun-Ming Huang, Ching-Wen Huang, Cheng-Jen Ma, et al.
Pathology Oncology Research : POR
|
May 12, 2019
Predictive Value of ERCC1, ERCC2, and XRCC Expression for Patients with Locally Advanced or Metastatic Gastric Cancer Treated with Neoadjuvant mFOLFOX-4 Chemotherapy
Yung-Sung Yeh, Yi-Ting Chen, Hsiang-Lin Tsai, et al.
International Journal of Colorectal Disease
|
October 30, 2025
Taiwan society of colon and rectal surgeons' consensus on the management of hemorrhoidal disease
Tsung-Kun Chang, Tao-Wei Ke, Pao-Shiu Hsieh, et al.
World Journal of Surgical Oncology
|
November 26, 2020
Impact of previous abdominal surgery on robotic-assisted rectal surgery in patients with locally advanced rectal adenocarcinoma: a propensity score matching study
Ching-Wen Huang, Wei-Chih Su, Tsung-Kun Chang, et al.
Pain and Therapy
|
September 29, 2020
Extended-Release Dinalbuphine Sebacate Versus Intravenous Patient-Controlled Analgesia with Fentanyl for Postoperative Moderate-to-Severe Pain: A Randomized Controlled Trial
Tsung-Kun Chang, Ching-Wen Huang, Wei-Chih Su, et al.
Oncology Research
|
October 25, 2024
Is ypTNM staging a comparable predictor as pTNM staging for survival in non-metastatic rectal cancer after preoperative chemoradiation therapy?
Jen-Pin Chuang, Hsiang-Lin Tsai, Wei-Chih Su, et al.
Page
of 20
Search research articles
Search
Showing results (151-160 of 193) with videos related to
Sort By:
Page
of 20
Translational Research : the Journal of Laboratory and Clinical Medicine
|
January 28, 2014
Prognostic advantage of irinotecan dose escalation according to uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) genotyping in patients with metastatic colorectal cancer treated with bevacizumab combined with 5-fluorouracil/leucovorin with irinotecan in a first-line setting
Chien-Yu Lu, Ching-Wen Huang, Huang-Ming Hu, et al.
Oncology Letters
|
August 13, 2020
Effect of <i>KRAS</i> and <i>NRAS</i> mutations on the prognosis of patients with synchronous metastatic colorectal cancer presenting with liver-only and lung-only metastases
Shih-Chang Chuang, Ching-Wen Huang, Yi-Ting Chen, et al.
Journal of Oncology
|
September 23, 2020
Observational Study Comparing Efficacy and Safety between Neoadjuvant Concurrent Chemoradiotherapy and Chemotherapy for Patients with Unresectable Locally Advanced or Metastatic Gastric Cancer
Yung-Sung Yeh, Ming-Yii Huang, Cheng-Jen Ma, et al.
BMC Cancer
|
December 17, 2013
The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer
Ching-Wen Huang, Hsiang-Lin Tsai, Yi-Ting Chen, et al.
Journal of Oncology
|
May 16, 2020
Predictive Value of FOLFOX-Based Regimen, Long Interval, Hemoglobin Levels and Clinical Negative Nodal Status, and Postchemoradiotherapy CEA Levels for Pathological Complete Response in Patients with Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy
Chun-Ming Huang, Ching-Wen Huang, Cheng-Jen Ma, et al.
Pathology Oncology Research : POR
|
May 12, 2019
Predictive Value of ERCC1, ERCC2, and XRCC Expression for Patients with Locally Advanced or Metastatic Gastric Cancer Treated with Neoadjuvant mFOLFOX-4 Chemotherapy
Yung-Sung Yeh, Yi-Ting Chen, Hsiang-Lin Tsai, et al.
International Journal of Colorectal Disease
|
October 30, 2025
Taiwan society of colon and rectal surgeons' consensus on the management of hemorrhoidal disease
Tsung-Kun Chang, Tao-Wei Ke, Pao-Shiu Hsieh, et al.
World Journal of Surgical Oncology
|
November 26, 2020
Impact of previous abdominal surgery on robotic-assisted rectal surgery in patients with locally advanced rectal adenocarcinoma: a propensity score matching study
Ching-Wen Huang, Wei-Chih Su, Tsung-Kun Chang, et al.
Pain and Therapy
|
September 29, 2020
Extended-Release Dinalbuphine Sebacate Versus Intravenous Patient-Controlled Analgesia with Fentanyl for Postoperative Moderate-to-Severe Pain: A Randomized Controlled Trial
Tsung-Kun Chang, Ching-Wen Huang, Wei-Chih Su, et al.
Oncology Research
|
October 25, 2024
Is ypTNM staging a comparable predictor as pTNM staging for survival in non-metastatic rectal cancer after preoperative chemoradiation therapy?
Jen-Pin Chuang, Hsiang-Lin Tsai, Wei-Chih Su, et al.
Page
of 20